Author:
Tian Rui,Wang Zerui,Zhang Shenglin,Wang Xiaojun,Zhang Yiwen,Yuan Jiaquan,Zhang Jiajun,Xu Feng,Chen Yuguo,Li Chuanbao
Funder
Taishan Scholar Project of Shandong Province
Natural Science Foundation of Shandong Province
National Natural Science Foundation of China
National Key Research and Development Program of China
Reference66 articles.
1. ST elevation myocardial infarction;Choudhury;Clin. Med.,2016
2. Mortality trends after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction;Thrane;J. Am. Coll. Cardiol.,2023
3. Timely and optimal treatment of patients with STEMI;Lassen;Nat. Rev. Cardiol.,2013
4. Novel insights into an "old" phenomenon: the no reflow;Durante;Int. J. Cardiol.,2015
5. A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention;Zeng;Anatol. J. Cardiol.,2021